The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai ...
Vietnam Investment Review on MSN
Kelun Biotech presents strategy at JPM conference
From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA.
India started a surveillance drive after two suspected Nipah virus cases were identified in West Bengal. The government ...
The results build on evidence U.S. regulators found so compelling last year they proactively awarded J&J a new kind of drug ...
We came across a bullish thesis on Genmab A/S on Gabriel Koh’s Substack. In this article, we will summarize the bulls’ thesis ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
Among patients with relapsed or refractory multiple myeloma, Tecvayli (teclistamab-cqyv) monotherapy was associated with a 71 ...
This time, Tecvayli excelled as a solo agent, reducing the risk of disease progression or death by 71% over standard of care ...
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC ...
ABL Bio is closing in on another partnership with a global pharmaceutical company for its proprietary Grabody-B technology, a ...
Celltrion’s senior executives attended the conference to present the company’s latest progress in new drug development and ...
Teclistamab plus daratumumab delivers unprecedented progression-free survival benefits over standard of care in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback